By virtue of its exclusive contract to manage the 340B Drug Pricing Program since 2004, Apexus has become a government-sanctioned entity fraught with self-dealing interests in the 340B marketplace.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results